Therapeutic Use of Parerythrobacter sp. M20A3S10, a Marine Bacterium, Targeting Influenza Viruses and Flaviviruses
Open Access
Abstract
Emerging RNA viruses such as influenza A virus (IAV), Zika virus (ZIKV), and dengue virus (DENV) continue to pose major challenges to animal and public health due to their high mutation rates, wide host ranges, and immune evasion strategies. In this study, we evaluated the in vitro antiviral activity of a marine bacterial extract derived from Parerythrobacter sp. M20A3S10 against IAV (H1N1; H3N2), influenza B virus (IBV), ZIKV, and DENV2. The extract demonstrated broad-spectrum antiviral effects with favorable selectivity indices across multiple host-derived epithelial cell lines. Notably, post-infection treatment significantly suppressed viral replication, suggesting a host-modulating or replication-inhibiting mechanism. While the extract’s active components have yet to be identified, bacteria from the Erythrobacteraceae family are known producers of bioactive metabolites with potential antiviral properties. These findings provide preliminary insight into the potential of marine-derived bacterial compounds in veterinary antiviral development and highlight the need for further characterization and in vivo validation. This work contributes to the understanding of virus–host interactions and the exploration of novel therapeutic strategies targeting the pathogenesis and immune modulation of veterinary RNA viruses.Keywords
Funding Information
- National Marine Biodiversity Institute of Korea (MABIK 2025M00600, RS-2024-00342230, 20250527000003426624)
- Korean government (MABIK 2025M00600, RS-2024-00342230, 20250527000003426624)
- Ministry of Education (MOE) and the Gwangju Metropolitan Government (MABIK 2025M00600, RS-2024-00342230, 20250527000003426624)
This publication has 34 references indexed in Scilit:
- Parerythrobacter aurantius sp. nov., a Member of the Family Erythrobacteraceae Isolated from a Coastal Breakwater StoneCurrent Microbiology, 2025
- Identification and characterization of a marine bacterium extract from Mameliella sp. M20D2D8 with antiviral effects against influenza A and B virusesArchives of Virology, 2024
- Alternative antiviral approaches to combat influenza A virusVirus Genes, 2022
- Therapeutic strategy targeting host lipolysis limits infection by SARS-CoV-2 and influenza A virusSignal Transduction and Targeted Therapy, 2022
- Broad-spectrum antiviral diazadispiroalkane core molecules block attachment and cell-to-cell spread of herpesvirusesAntiviral Research, 2022
- The evolution and future of influenza pandemic preparednessExperimental & Molecular Medicine, 2021
- The global distribution and burden of dengueNature, 2013
- Marine compounds and their antiviral activitiesAntiviral Research, 2010
- Influenza Virus Evolution, Host Adaptation, and Pandemic FormationCell Host & Microbe, 2010
- Evolutionary trees from DNA sequences: A maximum likelihood approachJournal of Molecular Evolution, 1981